Ueland, T., Åkerblom, A., Ghukasyan, T., Michelsen, A., Aukrust, P., Becker, R., … Trial, I. P. (2018). Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. Journal of the American Heart Association, 7(2). https://doi.org/10.1161/JAHA.117.007009 (Original work published 2018)

Vinereanu, D., Wang, A., Mulder, H., Lopes, R., Jansky, P., Lewis, B., … Alexander, J. (2018). Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease. Heart (British Cardiac Society). https://doi.org/10.1136/heartjnl-2017-312272 (Original work published 2018)

, Lu, Y., Highland, H., Schürmann, C., Justice, A., Fine, R., … Scientific, G. U. S. (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(5), 766-767. https://doi.org/10.1038/s41588-018-0082-3

, Lu, Y., Highland, H., Schürmann, C., Justice, A., Fine, R., … Scientific, G. U. S. (2018). Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(5), 765-766. https://doi.org/10.1038/s41588-018-0050-y

, Lu, Y., Highland, H., Schürmann, C., Justice, A., Fine, R., … Scientific, G. U. S. (2018). Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature Genetics, 50(1), 26-41. https://doi.org/10.1038/s41588-017-0011-x